tiprankstipranks
Trending News
More News >
Amplifon S.p.A. (IT:AMP)
:AMP
Advertisement

Amplifon S.p.A. (AMP) AI Stock Analysis

Compare
27 Followers

Top Page

IT

Amplifon S.p.A.

(LSE:AMP)

Rating:73Outperform
Price Target:
€22.50
▲(11.50%Upside)
Amplifon S.p.A. is supported by strong financial fundamentals, including consistent revenue growth and effective cash flow management. However, technical analysis suggests neutral market conditions, and the valuation appears relatively high, which may limit upside potential. The lack of recent earnings call insights or notable corporate events leaves some uncertainty.

Amplifon S.p.A. (AMP) vs. iShares MSCI Italy ETF (EWI)

Amplifon S.p.A. Business Overview & Revenue Model

Company DescriptionAmplifon S.p.A. is a global leader in hearing healthcare solutions, specializing in the provision of hearing aids and related services. Established in Italy, the company operates in multiple countries across Europe, the Americas, and the Asia-Pacific region. Amplifon's extensive network of retail outlets and service centers provides personalized hearing care and innovative audiology solutions to meet the needs of its customers.
How the Company Makes MoneyAmplifon makes money primarily through the sale of hearing aids and related products, which constitute the majority of its revenue. The company operates a retail network where it offers a range of branded and private label hearing devices. Additionally, Amplifon generates revenue from services such as hearing tests, customized fitting, and ongoing customer support. The company's growth is supported by partnerships with hearing aid manufacturers and audiologists, as well as its strategic acquisitions of local audiology companies to expand its market presence globally. Amplifon also benefits from recurring revenue streams through aftercare and maintenance services for its hearing aid customers.

Amplifon S.p.A. Financial Statement Overview

Summary
Amplifon S.p.A. demonstrates strong financial health with consistent revenue growth, efficient operations, and robust cash flow management. Despite moderate leverage on the balance sheet, the company's overall financial performance remains solid and resilient.
Income Statement
85
Very Positive
Amplifon S.p.A. has demonstrated strong revenue growth over the years, with a consistent increase in total revenue. The TTM (Trailing-Twelve-Months) shows a stable gross profit margin of approximately 56.6%, and a respectable net profit margin of 5.9%. The EBIT and EBITDA margins are 10.4% and 23.2%, respectively, indicating healthy operational efficiency. The company has effectively managed to grow its revenue from 2020 onwards, reflecting a solid upward trajectory.
Balance Sheet
78
Positive
The company's balance sheet reflects a moderately leveraged position with a debt-to-equity ratio of 1.53. The return on equity (ROE) stands at 12.6%, showcasing a decent return for shareholders. The equity ratio is 28.8%, indicating a stable financial structure despite high leverage. While the company is maintaining a solid equity base, the considerable amount of debt suggests potential risks in case of financial downturns.
Cash Flow
82
Very Positive
Amplifon S.p.A. exhibits strong cash flow management, with consistent operating cash flow generation. The free cash flow to net income ratio is 2.0, indicating efficient conversion of income into cash. The operating cash flow to net income ratio is 3.0, highlighting robust cash flow relative to net income. Although free cash flow growth has been slightly negative recently, the company maintains a healthy cash flow profile, supporting its operations and investments.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.43B2.41B2.26B2.12B1.95B1.56B
Gross Profit1.38B1.36B548.45M1.18B1.11B863.16M
EBITDA562.89M557.25M522.01M513.82M468.72M361.67M
Net Income143.78M145.37M155.14M178.53M157.78M101.00M
Balance Sheet
Total Assets3.97B3.99B3.69B3.58B3.52B3.23B
Cash, Cash Equivalents and Short-Term Investments261.40M288.85M194.00M229.54M318.44M554.02M
Total Debt1.74B1.72B1.52B1.50B1.61B1.56B
Total Liabilities2.82B2.84B2.59B2.54B2.59B2.43B
Stockholders Equity1.14B1.15B1.10B1.04B925.18M800.88M
Cash Flow
Free Cash Flow289.30M304.74M271.89M342.99M348.97M330.63M
Operating Cash Flow435.46M449.35M413.54M458.62M462.37M391.47M
Investing Cash Flow-311.15M-335.10M-261.48M-193.78M-533.61M-134.28M
Financing Cash Flow-75.62M-18.85M-135.06M-353.80M-208.64M151.52M

Amplifon S.p.A. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price20.18
Price Trends
50DMA
20.16
Negative
100DMA
19.49
Positive
200DMA
22.32
Negative
Market Momentum
MACD
-0.11
Positive
RSI
48.70
Neutral
STOCH
58.39
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IT:AMP, the sentiment is Positive. The current price of 20.18 is above the 20-day moving average (MA) of 20.09, above the 50-day MA of 20.16, and below the 200-day MA of 22.32, indicating a bearish trend. The MACD of -0.11 indicates Positive momentum. The RSI at 48.70 is Neutral, neither overbought nor oversold. The STOCH value of 58.39 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IT:AMP.

Amplifon S.p.A. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
ITGPI
78
Outperform
€416.50M4.01
6.03%16.92%
ITAMP
73
Outperform
€4.54B31.7612.59%1.45%5.71%-10.80%
ITPHN
66
Neutral
€446.29M26.99
4.05%17.78%63.72%
65
Neutral
¥347.74B11.06-2.99%2.55%11.77%-10.16%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IT:AMP
Amplifon S.p.A.
19.95
-9.28
-31.75%
IT:PHN
PharmaNutra SpA
45.70
-0.59
-1.27%
IT:GPI
GPI SpA
14.10
2.69
23.58%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 19, 2025